Joyce, A.T., Iacoviello, J.M., Nag, S., et al. (2004) Endstage renal disease-associated managed care costs among patients with and without diabetes. Diabetes Care, 27, 2829-2835. doi:10.2337/diacare.27.12.2829

has been cited by the following article:

• TITLE: Trends in use and costs of prescription medication in patients with type 1 diabetes: 9-year follow-up after kidney transplantation

  AUTHORS: Raija Lithovius, Valma Harjutsalo, Carol Forsblom, Markku Saraheimo, Petri Koskinen, Per-Henrik Groop

  KEYWORDS: Immunosuppressants; Kidney Transplantation; Medication Utilization; Costs; Prescription Medications; Type 1 Diabetes

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.3 No.1, February 7, 2013

  ABSTRACT: Aims: Weestimated long-term trends in prescription medication utilization and costs in patients with type 1 diabetes in two different transplant cohorts (Group 1: transplantation 1986-1999,n = 180; Group 2: transplantation 2000-2008, n = 150). Methods: Data obtained from the Finnish Diabetic Nephropathy Study were linked with the Drug Prescription Register (purchases of medications 1995-2009). Generalized linear mixed models under gamma distribution were used to evaluate the medication costs. Results: The total costs of medication decreased (Group 1 from€11,290 to €8760; Group 2 from €12,800 to €9790)during the follow-up (P